Suppression of T cell-induced osteoclast formation

Biochemical and Biophysical Research Communications

Volumn 436, Issue 4, 2013, Pages 619-624

  Karieb, Sahar ^a   Fox, Simon W ^a  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

Author keywords

Bone resorption; Phytoestrogens; T cell; TNF

Indexed keywords

CONCANAVALIN A; COUMESTROL; GENISTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; PHYTOESTROGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

BONE RESORPTION; PHYTOESTROGENS; T CELL; TNF-Α;

BASE SEQUENCE; CYTOKINES; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; OSTEOCLASTS; PHYTOESTROGENS; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 84880039006     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.140     Document Type: Article

References (37)

1. Redlich K., Smolen J.S. Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat. Rev. Drug Discovery 2012, 11:234-250.
2. Pacifici R. Role of T cells in ovariectomy induced bone loss-revisited. J. Bone Miner. Res. 2012, 27:231-239.
3. 3-induced class II transactivator. Proc. Natl. Acad. Sci. USA 2003, 100:10405-10410.
4. 2 signaling in T cells. Proc. Natl. Acad. Sci. USA 2004, 101:16618-16623.
5. Roggia C., Gao Y., Cenci S., Weitzmann M.N., Toraldo G., Isaia G., Pacifici R. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc. Natl. Acad. Sci. USA 2001, 98:13960-13965.
6. Cenci S., Weitzmann M.N., Roggia C., Namba N., Novack D., Woodring J., Pacifici R. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-a. J. Clin. Invest. 2000, 106:1229-1237.
7. Ryan M.R., Shepherd R., Leavey J.K., Gao Y., Grassi F., Schnell F.J., Qian W.-P., Kersh G.J., Weitzmann M.N., Pacifici R. An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency. Proc. Natl. Acad. Sci. USA 2005, 102:16735-16740.
8. Gao Y., Grassi F., Ryan M.R., Terauchi M., Page K., Yang X., Weitzmann M.N., Pacifici R. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J. Clin. Invest. 2007, 117:122-132.
9. Barbour K.E., Boudreau R., Danielson M.E., Youk A.O., Wactawski-Wende J., Greep N.C., LaCroix A.Z., Jackson R.D., Wallace R.B., Bauer D.C., Allison M.A., Cauley J.A. Inflammatory markers and the risk of hip fracture: the women's health initiative. J. Bone Miner. Res. 2012, 27:1167-1176.
10. Pacifici R., Brown C., Puscheck E., Friedrich E., Slatopolsky E., Maggio D., McCracken R., Avioli L. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. USA 1991, 88:5134-5138.
11. Ralston S.H., Russell R.G., Gowen M. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women. J. Bone Miner. Res. 1990, 5:983-988.
12. D'Amelio P., Grimaldi A., Pescarmona G.P., Tamone C., Roato I., Isaia G. Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis. FASEB J. 2004, 19:410-412.
13. Komine M., Kukita A., Kukita T., Ogata Y., Hotokebuchi T., Kohashi O. Tumor necrosis factor-[alpha] cooperates with receptor activator of nuclear factor [kappa]B ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture. Bone 2001, 28:474-483.
14. Fox S.W., Evans K.E., Lovibond A.C. Transforming growth factor-[beta] enables NFATc1 expression during osteoclastogenesis. Biochem. Biophys. Res. Commun. 2008, 366:123-128.
15. Kudo O., Fujikawa Y., Itonaga I., Sabokbar A., Torisu T., Athanasou N.A. Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation. J. Pathol. 2002, 198:220-227.
16. Cole Z., Dennison E., Cooper C. Update on the treatment of post-menopausal osteoporosis. Br. Med. Bull. 2008, 86:129-143.
17. Horiuchi T., Onouchi T., Takahashi M., Ito H., Orimo H. Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos. Int. 2000, 11:721-724.
18. Kim M.K., Chung B.C., Yu V.Y., Nam J.H., Lee H.C., Huh K.B., Lim S.K. Relationships of urinary phyto-oestrogen excretion to BMD in postmenopausal women. Clin. Endocrinol. 2002, 56:321-328.
19. Mei J., Yeung S.S.C., Kung A.W.C. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J. Clin. Endocrinol. Metab. 2001, 86:5217-5221.
20. Weaver C.M., Martin B.R., Jackson G.S., McCabe G.P., Nolan J.R., McCabe L.D., Barnes S., Reinwald S., Boris M.E., Peacock M. Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using 41Ca methodology. J. Clin. Endocrinol. Metab. 2009, 94:3798-3805.
21. Alekel D.L., Germain A.S., Peterson C.T., Hanson K.B., Stewart J.W., Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am. J. Clin. Nutr. 2000, 72:844-852.
22. Atkinson C., Compston J.E., Day N.E., Dowsett M., Bingham S.A. The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr. 2004, 79:326-333.
23. Chen Y.-M., Ho S.C., Lam S.S.H., Ho S.S.S., Woo J.L.F. Soy isoflavones have a favorable effect on bone loss in chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J. Clin. Endocrinol. Metab. 2003, 88:4740-4747.
24. Wu J., Oka J., Tabata I., Higuchi M., Toda T., Fuku N., Ezaki J., Sugiyama F., Uchiyama S., Yamada K., Ishimi Y. Effects of isoflavone and exercise on BMD and fat mass in postmenopausal Japanese women: a 1-year randomized placebo-controlled trial. J. Bone Miner. Res. 2006, 21:780-789.
25. Burstone M.S. Histochemical demonstration of acid phosphatases with naphthol AS-phosphates. J. Natl. Cancer 1958, 1(21):523-539.
26. Weitzmann M.N., Pacifici R. T cells: unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis. Ann. N. Y. Acad. Sci. 2007, 1116:360-375.
27. Karieb S., Fox S.W. Phytoestrogens directly inhibit TNF-alpha-induced bone resorption in RAW264.7 cells by suppressing c-fos-induced NFATc1 expression. J. Cell. Biochem. 2011, 112:476-487.
28. Wyzga N., Varghese S., Wikel S., Canalis E., Sylvester F.A. Effects of activated T cells on osteoclastogenesis depend on how they are activated. Bone 2004, 35:614-620.
29. Kawai T., Matsuyama T., Hosokawa Y., Makihira S., Seki M., Karimbux N.Y., Goncalves R.B., Valverde P., Dibart S., Li Y.P., Miranda L.A., Ernst C.W., Izumi Y., Taubman M.A. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am. J. Pathol. 2006, 169:987-998.
30. Beech J.T., Andreakos E., Ciesielski C.J., Green P., Foxwell B.M., Brennan F.M. T-cell contact-dependent regulation of CC and CXC chemokine production in monocytes through differential involvement of NFkappaB: implications for rheumatoid arthritis. Arthritis Res. Ther. 2006, 8:R168.
31. Li L., Qiao D., Fu X., Lao S., Zhang X., Wu C. Identification of mycobacterium tuberculosis-specific Th1, Th17 and Th22 cells using the expression of CD40L in tuberculous pleurisy. PLoS One 2011, 6:e20165.
32. Islam S., Hassan F., Tumurkhuu G., Dagvadorj J., Koide N., Naiki Y., Yoshida T., Yokochi T. Receptor activator of nuclear factor-kappa B ligand induces osteoclast formation in RAW264.7 macrophage cells via augmented production of macrophage-colony-stimulating factor. Microbiol. Immunol. 2008, 52:585-590.
33. Horwood N.J., Kartsogiannis V., Quinn J.M., Romas E., Martin T.J., Gillespie M.T. Activated T lymphocytes support osteoclast formation in vitro. Biochem. Biophys. Res. Commun. 1999, 265:144-150.
34. Belibasakis G.N., Brage M., Lagergard T., Johansson A. Cytolethal distending toxin upregulates RANKL expression in Jurkat T-cells. APMIS 2008, 116:499-506.
35. Baxa D.M., Luo X., Yoshimura F.K. Genistein induces apoptosis in T lymphoma cells via mitochondrial damage. Nutr. Cancer 2005, 51:93-101.
36. Yamasaki M., Fujita S., Ishiyama E., Mukai A., Madhyastha H., Sakakibara Y., Suiko M., Hatakeyama K., Nemoto T., Morishita K., Kataoka H., Tsubouchi H., Nishiyama K. Soy-derived isoflavones inhibit the growth of adult T-cell leukemia cells in vitro and in vivo. Cancer Sci. 2007, 98:1740-1746.
37. Duan W., Kuo I.C., Selvarajan S., Chua K.Y., Bay B.H., Wong W.S. Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma. Am. J. Respir. Crit. Care Med. 2003, 167:185-192.